La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Movement Disorders (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Movement Disorders (diagnostic imaging) < Movement Disorders (drug therapy) < Movement Disorders (epidemiology)  Facettes :

List of bibliographic references indexed by Movement Disorders (drug therapy)

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000A35 (2014) St Masoud [Canada] ; Lm Vecchio [Canada] ; Y. Bergeron ; Mm Hossain [États-Unis] ; Lt Nguyen [Canada] ; Mk Bermejo [Canada] ; B. Kile [États-Unis] ; Td Sotnikova [Italie, Russie] ; Wb Siesser [États-Unis] ; Rr Gainetdinov [Italie, Russie] ; Rm Wightman [États-Unis] ; Mg Caron [États-Unis] ; Jr Richardson [États-Unis] ; Gw Miller [États-Unis] ; Aj Ramsey [Canada] ; M. Cyr ; A. Salahpour [Canada]Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits
000E88 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
001E25 (2009) Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
001E74 (2009) Neema Kasravi [Canada] ; Mandar S. JogBotulinum toxin in the treatment of lingual movement disorders.
002B76 (2004) Simon Lemay [Canada] ; Sylvain Chouinard ; Pierre Blanchet ; Hélène Masson ; Valérie Soland ; Anne Beuter ; Marc-André BédardLack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
003585 (2000) R. De La Fuente-Fernandez [Canada] ; P. K. Pal [Canada] ; F. J. G. Vingerhoets [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; T. J. Ruth [Canada] ; B. J. Snow [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada]Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
003625 (1999) R. Grondin [Canada] ; V D Doan ; L. Grégoire ; P J BédardD1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.
003C03 (1997) J. T. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; Alex Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada]Concordance of common movement disorders among familial cases
003E86 (1996) P. J. Blanchet [Canada] ; P. Allard [Canada] ; L. Gregoire [Canada] ; F. Tardif [Canada] ; P. J. Bedard [Canada]Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients
004308 (1993) A G Parrent [Canada] ; R R Tasker ; J O DostrovskyTremor reduction by microinjection of lidocaine during stereotactic surgery.
004634 (1992) A. J. Stoessl [Canada]Prevention and management of late stage complications in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Movement Disorders (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Movement Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Movement Disorders (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022